GeneDx (WGS) Stock: Buy, Sell, or Hold?
WGS - GeneDx Holdings Corp. Class A Common Stock
$68.94
0.20 (0.29%)
▲
5d:
+0.48%
30d:
-24.07%
90d:
+8.77%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 27, 2026
5d
Get Alerted When WGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: WGS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: WGS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$58.35
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$36.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WGS is currently trading at $68.94, which is considered slightly low relative to its 30-day fair value range of $66.11 to $91.26. From a valuation perspective, the stock is trading at a discount (Forward PE: 57.5) compared to its historical average (99.9). Remarkably, the market is currently pricing in an annual earnings decline of 16.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, WGS is in a strong uptrend. Immediate support is located at $62.01, while resistance sits at $72.70.
Market Sentiment: WGS scores 96/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $93.50 (+35.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, WGS is in a strong uptrend. Immediate support is located at $62.01, while resistance sits at $72.70.
Market Sentiment: WGS scores 96/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $93.50 (+35.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$66.11 -
$91.26
Company Quality Score
77/100
(STRONG BUY)
Volume Confirmation
HIGH
Confidence Score
92.3%
Protect Your Profits
Holding WGS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (96/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 35.6% below Wall St target ($93.50)
- CAUTION: Bottoming setup, but lagging the sector by 11% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$66.11 -
$91.26
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$10.19
(14.8%)
Support & Resistance Levels
Support Level
$62.01
Resistance Level
$72.70
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
57.52
Wall Street Target
$93.50
(+35.6%)
Revenue Growth (YoY)
11.4%
Profit Margin
-23.4%
Valuation Discount vs History
-16.8% cheaper
PE vs Historical
57.5 vs 99.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.8%
(market-implied from PE analysis)
1-Year Target
$62.05
(-10%)
2-Year Target
$55.84
(-19%)
3-Year Target
$50.26
(-27%)
3-Yr Target (if PE normalizes)
(PE: 58→100)
$87.29
(+27%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 57.5, Growth: 812.2%)
$232.67
(+238%)
Base:
(SPY PE: 19.9, Growth: 812.2%)
$80.34
(+17%)
Bear:
(PE: 16.9, Growth: 812.2%)
$68.29
(-1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 57.5 to 99.9
Stabilization Target:
$119.74
(+73.7%)
PE Expansion Potential:
+73.7%
Share & Embed Analysis
Last updated: October 21, 2026 6:31 PM ET
Data refreshes hourly during market hours. Next update: 7:31 PM
Data refreshes hourly during market hours. Next update: 7:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WGS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 61 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 42 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 40 SELL |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 44 HOLD |
Advanced WGS Option Strategies
Professional options setups generated by AI based on today's WGS price and gamma walls.
